» Articles » PMID: 28088293

The Essentiality of Arachidonic Acid in Addition to Docosahexaenoic Acid for Brain Growth and Function

Overview
Specialty Endocrinology
Date 2017 Jan 16
PMID 28088293
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The essentiality of arachidonic acid (ARA) and docosahexaenoic acid (DHA) for growth and brain function using delta-6-desaturase knockout (D6D-KO) mice and a novel artificial rearing method was investigated. Newborn male wild type (WT) and homozygous D6D-KO pups were separated from their dams within 48h and fed artificial milk containing α-linolenic acid and linoleic acid (Cont), or supplemented with ARA, DHA or both (ARA+DHA). After weaning, each group was fed diets similar to artificial milk in fatty acid composition for 7 weeks. KO-Cont showed a lower body weight than WT-Cont. When ARA was added to the control diet, (KO-ARA and KO-ARA+DHA diets) the body weight gain was restored. The KO-DHA group was initially similar to the WT groups for the first 6 weeks, but afterwards their body weight was significantly lower. Brain weight in the 10 week old KO-ARA+DHA group was significantly higher within the KO dietary groups. Motor activity of the KO-ARA and KO-ARA+DHA groups was elevated relative to the KO-Cont group but the KO-ARA+DHA group exhibited similar activity to the WT-Cont group. In the motor coordination ability test, the KO-Cont group performed significantly worse compared with the WT-Cont group. KO-ARA mice showed decreased motor coordination in spite of their increased motor activity. The best performance was observed in only KO-ARA+DHA mice. These experiments demonstrated that supplementation with only ARA or only DHA was insufficient for optimal development. ARA was essential for normal growth within the lactation period. In conclusion, only the combination of preformed ARA and DHA was capable of improving the dysfunction caused by D6D deficiency.

Citing Articles

Successful Nutritional Intervention for an Infant with Abetalipoproteinemia: A Novel Modular Formula (AbetaMF).

Ueda M, Maeda M, Burke F, Hegele R, Gleghorn E, Rader D JPGN Rep. 2023; 2(1):e049.

PMID: 37206948 PMC: 10191596. DOI: 10.1097/PG9.0000000000000049.


Characterization of the fatty acid profile in the ventral midbrain of mice exposed to dietary imbalance between omega-6 and omega-3 fatty acids during specific life stages.

Sakayori N, Katakura M, Setogawa S, Sugita M, Kobayashi K BMC Res Notes. 2022; 15(1):285.

PMID: 36064737 PMC: 9446585. DOI: 10.1186/s13104-022-06175-0.


Roles of the Unsaturated Fatty Acid Docosahexaenoic Acid in the Central Nervous System: Molecular and Cellular Insights.

Petermann A, Reyna-Jeldes M, Ortega L, Coddou C, Yevenes G Int J Mol Sci. 2022; 23(10).

PMID: 35628201 PMC: 9141004. DOI: 10.3390/ijms23105390.


Long-Chain Polyunsaturated Fatty Acids and Their Metabolites Regulate Inflammation in Age-Related Macular Degeneration.

Ren J, Ren A, Deng X, Huang Z, Jiang Z, Li Z J Inflamm Res. 2022; 15:865-880.

PMID: 35173457 PMC: 8842733. DOI: 10.2147/JIR.S347231.


Perinatal Dietary Polyunsaturated Fatty Acids in Brain Development, Role in Neurodevelopmental Disorders.

Martinat M, Rossitto M, Di Miceli M, Laye S Nutrients. 2021; 13(4).

PMID: 33918517 PMC: 8065891. DOI: 10.3390/nu13041185.